Literature DB >> 19574484

Incidence of second cancers after allogeneic hematopoietic stem cell transplantation using reduced-dose radiation.

Matthew M Hsieh, Courtney D Fitzhugh, John F Tisdale.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19574484      PMCID: PMC2710951          DOI: 10.1182/blood-2009-03-209015

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  Radiation-related cancer risks at low doses among atomic bomb survivors.

Authors:  D A Pierce; D L Preston
Journal:  Radiat Res       Date:  2000-08       Impact factor: 2.841

2.  Solid cancers after bone marrow transplantation.

Authors:  R E Curtis; P A Rowlings; H J Deeg; D A Shriner; G Socíe; L B Travis; M M Horowitz; R P Witherspoon; R N Hoover; K A Sobocinski; J F Fraumeni; J D Boice
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

3.  Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997.

Authors:  Dale L Preston; Yukiko Shimizu; Donald A Pierce; Akihiko Suyama; Kiyohiko Mabuchi
Journal:  Radiat Res       Date:  2003-10       Impact factor: 2.841

4.  Solid cancers after allogeneic hematopoietic cell transplantation.

Authors:  J Douglas Rizzo; Rochelle E Curtis; Gérard Socié; Kathleen A Sobocinski; Ethel Gilbert; Ola Landgren; Lois B Travis; William D Travis; Mary E D Flowers; Debra L Friedman; Mary M Horowitz; John R Wingard; H Joachim Deeg
Journal:  Blood       Date:  2008-10-29       Impact factor: 22.113

  4 in total
  1 in total

Review 1.  Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.

Authors:  Gregory M T Guilcher; Tony H Truong; Santosh L Saraf; Jacinth J Joseph; Damiano Rondelli; Matthew M Hsieh
Journal:  Semin Hematol       Date:  2018-04-25       Impact factor: 3.851

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.